Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors
Dongwei Kang(Shandong University), Xinyong Liu(Shandong University of Traditional Chinese Medicine), Boshi Huang(Virginia Commonwealth University), Christophe Pannecouque(Rega Institute for Medical Research), Erik De Clercq(Rega Institute for Medical Research), Gaochan Wu(Shandong University), Xiaofang Zuo(Shandong University), Fenju Wei(Shandong University), Zhongxia Zhou(Shandong University), Peng Zhan(Shandong University of Traditional Chinese Medicine), Jacob Kongsted(University of Southern Denmark), Heng Zhang(Shandong University), Zhao Wang(Shandong University), Ye Tian(Jilin University), Da Feng(Shandong University), Lanlan Jing(Shandong University), Tong Zhao(China Pharmaceutical University), Vasanthanathan Poongavanam(University of Southern Denmark)
Cited by 32
Related Papers
Therapeutic strategies for COVID-19: progress and lessons learned
|Nature Reviews Drug Discovery|2023|671
Antiviral agents active against influenza A viruses
|Nature Reviews Drug Discovery|2006|666
Overview of Recent Strategic Advances in Medicinal Chemistry
|Journal of Medicinal Chemistry|2019|181
Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent
|Antimicrobial Agents and Chemotherapy|2008|115
New Class of HIV Integrase Inhibitors that Block Viral Replication in Cell Culture
|Current Biology|2002|100